Revolution Medicines reported Phase 3 data this week showing its oral drug daraxonrasib nearly doubled median overall survival in advanced pancreatic adenocarcinoma: 13.2 months versus 6.7 months for standard chemotherapy. The result is striking in a cancer where treatment options have remained limited and prognosis has historically been poor. Revolution intends to file for FDA approval using the dataset, though no submission timeline has been announced. Paul Oberstein of NYU Langone's Perlmutter Cancer Center, a trial investigator, described the findings as potentially opening a new era of treatment for the disease. Fast-track or priority review pathways could accelerate the approval process once a submission is made, given the magnitude of benefit over existing standard of care. Investors and oncology specialists will be watching for the FDA submission date, full survival curve data, and any subgroup analyses that define which patient populations benefit most from the daily pill format over intravenous chemotherapy.
Apple has raised MacBook and iPad prices in India by 20% to 42%, citing a sharp surge in memory chip costs driven by AI data centre demand. Micron, the leading memory supplier, reported 86% gross margins, confirming that supply pressures have fundamentally shifted component pricing across the consumer electronics
India's central government will take a 1-2% stake in AI unicorn Sarvam once its $300 million funding round closes, converting compute subsidies provided under the IndiaAI Mission into equity. The move sets a precedent for how the government accounts for public support given to homegrown AI startups.
Apple announced iOS 27 at WWDC 2026, featuring a redesigned Siri as a standalone app with chat history, apps launching up to 30 percent faster, and a refined Liquid Glass interface. A developer preview is live now, with public release expected around September 2026.
Apple's WWDC 2026 keynote unveiled a fully redesigned Siri and confirmed iOS 27 alongside updates for iPadOS, visionOS, watchOS, and macOS. The Siri overhaul is the most strategically significant move, targeting a competitive gap with Google and Microsoft in AI assistants.
